Eur J Clin Invest 2012; 42 (9): 983–991 Abstract Background Research concerning the
involvement of body composition and systemic inflammatory markers in adipokine …

Rationale: Two adipokines, leptin and adiponectin, regulate metabolic and inflammatory
systems reciprocally. The role of adiponectin in chronic obstructive pulmonary disease …

BACKGROUND: COPD is characterized by a multi-component character involving a state of
low-grade systemic inflammation and an increased prevalence of cardiovascular co …

BACKGROUND: Adiponectin is an anti-inflammatory adipokine that may play a role in
chronic obstructive pulmonary disease (COPD) pathogenesis. OBJECTIVE: To investigate …

Background and objective. Adiponectin is an adipose tissue‐derived specific protein that
has a role in energy homeostasis, that has a protective role against the development of …

Objectives Adipokines are protein mediators first described as products of adipose tissue
regulating energy metabolism and appetite. Recently, adipokines have also been found to …

Rationale: The rate of annual change in FEV1 is highly variable among patients with chronic
obstructive pulmonary disease (COPD). Reliable blood biomarkers are needed to predict …

Adipose tissue produces leptin and adiponectin–energy-regulating adipokines that may also
play a role in inflammatory pulmonary conditions, as suggested by some murine studies …

Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease
which may be complicated by development of co-morbidities including metabolic disorders …

Background Weight loss and muscle wasting are common features reported in COPD
patients and they are all related with systemic inflammation. In this study, the relationship …